Proarrhythmia is a new or more frequent occurrence of pre-existing arrhythmias, paradoxically precipitated by antiarrhythmic therapy, which means it is...
2 KB (267 words) - 20:51, 8 February 2021
antiarrhythmics, such as encainide. The risk of proarrhythmia may also be increased by hypokalemia. The risk of proarrhythmia is not necessarily associated with the...
25 KB (2,632 words) - 13:08, 23 March 2024
Approximately 2 to 7 percent of patients taking at least 320 mg/day experience proarrhythmia, most often in the form of TdP. The risks and effects are dose-dependent...
17 KB (2,162 words) - 18:26, 3 September 2024
and training in safety pharmacology. CiPA: Comprehensive in vitro Proarrhythmia Assay (2013)[10]: In the coming years, the FDA plans to update the current...
11 KB (1,337 words) - 11:36, 7 October 2023
Mercola, Mark (January 2023). "A deep learning platform to assess drug proarrhythmia risk". Cell Stem Cell. 30 (1): 86–95.e4. doi:10.1016/j.stem.2022.12...
92 KB (10,512 words) - 19:18, 10 October 2024
Veterinary Therapy XV 2014 Roden, DM., Mechanism and management of proarrhythmia. Am J Cardiol 20 August 1998;82(4A):49I-57I. O. Lynne Nelson, Sunshine...
8 KB (1,029 words) - 04:23, 16 February 2023
Capone R (1994). "New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia...
6 KB (557 words) - 13:11, 11 October 2024
Syril; Stockbridge, Norman (March 2014). "Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium"...
26 KB (3,098 words) - 00:59, 24 October 2024